Related Experiment Video

Updated: Jun 29, 2026

Ultrastructural Expansion Microscopy in Three In Vitro Life Cycle Stages of Trypanosoma cruzi
09:45

Ultrastructural Expansion Microscopy in Three In Vitro Life Cycle Stages of Trypanosoma cruzi

Published on: May 12, 2023

Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study

Rubem F S Menna-Barreto1, Kelly Salomão, Andréia P Dantas

  • 1Laboratório de Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ 21040-900, Brazil.

Micron (Oxford, England : 1993)
|October 14, 2008
PubMed

Insights

Investigating new Chagas disease drugs, this review explores agents inducing cell death in Trypanosoma cruzi. Diverse compounds trigger similar ultrastructural changes, particularly mitochondrial damage and autophagy, suggesting cross-talk between cell death pathways.

Area of Science:

  • Parasitology
  • Cell Biology
  • Drug Discovery

Background:

  • Chagas disease remains a significant health concern, necessitating novel therapeutic strategies.
  • Electron microscopy is crucial for identifying morphological changes in Trypanosoma cruzi induced by potential drugs.
  • Understanding parasite cell death mechanisms is key to developing effective treatments.

Purpose of the Study:

  • To review and evaluate various agents that induce programmed cell death (PCD) in Trypanosoma cruzi.
  • To analyze the ultrastructural alterations and cellular pathways involved in parasite death.
  • To identify commonalities and cross-talk between different PCD pathways.

Main Methods:

  • Review of scientific literature on agents targeting Trypanosoma cruzi.
  • Analysis of electron microscopy data detailing morphological changes.
  • Categorization of cell death mechanisms: apoptosis-like, autophagy, and necrosis.

Main Results:

  • Lysophospholipid analogues disrupt lipid biosynthesis and membrane properties.
  • Naphthoquinone derivatives cause DNA fragmentation and protease release, leading to cell death.
  • Cytoskeletal inhibitors block mitosis, arresting parasite proliferation.
  • Mitochondrial alterations and autophagic phenotypes are common across different drug treatments.
  • Evidence suggests cross-talk between apoptosis, autophagy, and necrosis in Trypanosoma cruzi.

Conclusions:

  • Diverse therapeutic agents converge on similar cell death pathways in Trypanosoma cruzi.
  • Mitochondrial integrity and autophagy are critical in parasite response to drug treatment.
  • Targeting these pathways offers potential for novel Chagas disease drug development.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs08:17

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs

Published on: June 23, 2022

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...